New permits show that Dallas will likely land $1.2B Morgan Stanley tower.
Morgan Stanley initiated Revolution Medicines (RVMD) with an overweight rating, saying that the precision oncology therapy developer's pipeline of RAS(“ON”) inhibitors will lead to long-term success.
Morgan Stanley surged on capital markets strength but now trades at a premium valuation. Click here to read my latest ...
Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 24th Annual Global Healthcare Conference on ...
AI cloud infrastructure names are moving higher Tuesday morning after a sell-side re-rating on Oracle (NYSE:ORCL | ORCL Price ...
Morgan Stanley has signed a lease for downtown Dallas' Fountain Place skyscraper. A new face is coming to Y'all Street.
Meta shares have been on a tear lately, but the longer look is more sobering. The stock is up 9.97% over the past week and ...
Earnings estimates are starting to pick up for artificial-intelligence adopters — and their stocks are due to rise as well, ...
Morgan Stanley complained to X about posts on the social media site using the bank’s charts and research, leading to at least ...
Data center developers have run into local opposition across the US this year. Market pros say the bottleneck could be a ...
Morgan Stanley urges pre-retirees to tackle high-interest debt, but the guide never spells out how mortgage rate and cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results